Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence

Despite recent advances in cancer therapeutics, pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year overall survival of only 10%. Since either at or within a few months of diagnosis, most patients with PDAC will present with metastatic disease, a more individualized approa...

Full description

Bibliographic Details
Main Authors: Orimisan Samuel Adekolujo, Ahsan Wahab, Maxwell Oluwole Akanbi, Tolutope Oyasiji, Borys Hrinczenko, Olatunji Boladale Alese
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Cancer Biology & Therapy
Subjects:
Online Access:http://dx.doi.org/10.1080/15384047.2023.2198479

Similar Items